HighQC™ Human Neonatal Cardiac Stem Cell

Description

HighQC™ Human Neonatal Cardiac Stem Cells are isolated from neonatal human heart tissue obtained from healthy donors, and enriched based on the expression of cardiac progenitor markers such as c-Kit, Sca-1, and Troponin. These cells exhibit spindle-shaped morphology and demonstrate strong proliferative capacity while retaining multipotency. They are maintained at early passages to ensure karyotypic stability and phenotypic consistency. They can differentiate into major cardiac lineages including cardiomyocytes, endothelial cells, and smooth muscle cells under specific conditions. Neonatal cardiac stem cells show enhanced regenerative potential compared to adult counterparts, making them a powerful model for cardiac development and repair. They express early cardiac transcription factors and maintain the ability to form contractile cardiomyocyte-like cells in vitro. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.